Pulmonary nocardiosis during immunosuppressive therapy for idiopathic pulmonary fibrosis

Respirology. 2000 Dec;5(4):393-5.

Abstract

Nocardiosis is a subacute or chronic suppurative infection caused by Nocardia species. Although it is more common in immunocompromised hosts, idiopathic pulmonary fibrosis (IPF) has not been recognized as a predisposing factor for nocardial infection. We report a case of IPF, in which pulmonary nocardiosis developed during treatment with prednisolone and cyclophosphamide. The risk of pulmonary nocardiosis may be increased in cases of IPF on immunosuppressive therapy. Since IPF often accompanies lung carcinoma, it is important to correctly differentiate nocardiosis from carcinoma.

Publication types

  • Case Reports

MeSH terms

  • Aged
  • Anti-Bacterial Agents / therapeutic use
  • Causality
  • Cyclophosphamide / adverse effects*
  • Drug Therapy, Combination
  • Humans
  • Immunocompromised Host*
  • Immunosuppressive Agents / adverse effects*
  • Male
  • Minocycline / therapeutic use
  • Nocardia Infections / chemically induced*
  • Nocardia Infections / diagnostic imaging
  • Nocardia Infections / drug therapy
  • Nocardia Infections / microbiology
  • Pneumonia, Bacterial / chemically induced*
  • Pneumonia, Bacterial / diagnostic imaging
  • Pneumonia, Bacterial / drug therapy
  • Pneumonia, Bacterial / microbiology
  • Prednisolone / adverse effects*
  • Pulmonary Fibrosis / drug therapy*
  • Pulmonary Fibrosis / immunology
  • Sputum / microbiology
  • Tomography, X-Ray Computed

Substances

  • Anti-Bacterial Agents
  • Immunosuppressive Agents
  • Cyclophosphamide
  • Prednisolone
  • Minocycline